1. Home
  2. INBK vs TNXP Comparison

INBK vs TNXP Comparison

Compare INBK & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Internet Bancorp

INBK

First Internet Bancorp

HOLD

Current Price

$25.36

Market Cap

179.3M

Sector

Finance

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$14.08

Market Cap

198.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INBK
TNXP
Founded
1999
2007
Country
United States
United States
Employees
355
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.3M
198.6M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
INBK
TNXP
Price
$25.36
$14.08
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$23.25
N/A
AVG Volume (30 Days)
54.2K
392.8K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
1.06%
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$279.34
$558.11
Revenue Next Year
$12.97
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.85
52 Week Low
$17.05
$11.60
52 Week High
$28.51
$69.65

Technical Indicators

Market Signals
Indicator
INBK
TNXP
Relative Strength Index (RSI) 68.25 53.38
Support Level $21.25 $13.32
Resistance Level N/A $14.52
Average True Range (ATR) 1.09 0.79
MACD 0.17 0.16
Stochastic Oscillator 90.77 63.52

Price Performance

Historical Comparison
INBK
TNXP

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: